Acarbose
Acarbose is an oral diabetes medicine used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 8 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Acarbose is an older type 2 diabetes medicine that blocks gut enzymes that digest carbohydrates, blunting the blood sugar spike after meals; on the U.S. market for well over a decade and available as a generic, it is usually an add-on rather than a first choice. On its own it rarely causes low blood sugar, but gas, bloating and diarrhea are very common at first and often ease over time, especially if you go easy on sugary foods. The one thing to watch is your liver, so get prompt care for yellowing skin or eyes, dark urine or severe fatigue, and expect liver blood tests in the first year.
Clinical pearls
- Take it with the first bite of each main meal, and if you skip a meal, skip that dose too.
- On insulin or a sulfonylurea, treat low blood sugar with glucose tablets or gel, since acarbose slows table sugar’s breakdown.
- Persistent diarrhea, rectal bleeding or mucus in your stool is not ordinary gas; stop acarbose and call your doctor promptly.
- Avoid activated charcoal and digestive enzyme supplements such as pancreatin alongside acarbose, since they weaken its effect.
Patient information guide A plain-language walkthrough of Acarbose, written from its FDA label.
What Acarbose is used for
▾
Acarbose tablets are approved for one main use in adults:
- Type 2 diabetes: Acarbose tablets are used as an add-on to diet and exercise to improve blood sugar (glycemic) control in adults with type 2 diabetes. They can be used alone or combined with sulfonylureas, insulin, or metformin.
How Acarbose works
▾
Acarbose works entirely inside your digestive tract. It blocks two key enzymes — pancreatic alpha-amylase and intestinal alpha-glucosidase — that normally break complex carbohydrates down into glucose. By slowing this breakdown, acarbose delays how quickly sugar enters your bloodstream after a meal, reducing the post-meal blood sugar spike. Importantly, it does not stimulate insulin release the way some other diabetes medicines do.
Because acarbose's action happens locally in the gut and very little is absorbed into the body, its blood-sugar-lowering effect adds on top of other diabetes medicines without overlapping their mechanisms — making it a useful combination partner.
Acarbose dosage
▾
Acarbose tablets are taken by mouth three times a day, always at the very start of a main meal — with the first bite. Timing with food is essential; the medicine must be present when carbohydrates arrive in the gut to work properly.
- Your doctor will start you at a low dose and increase it gradually over weeks to months based on your blood sugar response and how well you tolerate it.
- Your dose may be adjusted every 4 to 8 weeks based on after-meal blood sugar readings or your hemoglobin A1c level.
- If stomach side effects are bothersome, do not stop on your own — talk to your doctor, who may temporarily lower the dose.
Dosing details from the FDA-approved label
From the Acarbose prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Initial dosage (type 2 diabetes mellitus)
- 25 mg given orally three times daily at the start (with the first bite) of each main meal
- Some patients may benefit from starting at 25 mg once per day and subsequently increasing the frequency to achieve 25 mg t.i.d
- More gradual titration may minimize gastrointestinal side effects
- Maintenance dosage
- Once 25 mg t.i.d. is reached, adjust at 4 to 8 week intervals based on one-hour postprandial glucose or glycosylated hemoglobin levels and tolerance
- May increase from 25 mg t.i.d. to 50 mg t.i.d., and some patients may benefit from 100 mg t.i.d
- Maintenance dose ranges from 50 mg t.i.d. to 100 mg t.i.d
- Maximum: 100 mg t.i.d.
- Only patients with body weight > 60 kg should be considered for dose titration above 50 mg t.i.d.
- Patients with body weight ≤ 60 kg
- Maximum recommended dose is 50 mg t.i.d
- Maximum: 50 mg t.i.d.
- Low body weight may be at increased risk for elevated serum transaminases
- Patients with body weight > 60 kg
- Maximum recommended dose is 100 mg t.i.d
- Maximum: 100 mg t.i.d.
- Patients receiving sulfonylureas or insulin
- Acarbose given in combination with a sulfonylurea or insulin will cause a further lowering of blood glucose and may increase the potential for hypoglycemia
- If hypoglycemia occurs, make appropriate adjustments in the dosage of these agents
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION There is no fixed dosage regimen for the management of diabetes mellitus with Acarbose Tablets or any other pharmacologic agent. Dosage of Acarbose Tablets must be individualized on the basis of both effectiveness and tolerance while not exceeding the maximum recommended dose of 100 mg t.i.d. Acarbose Tablets should be taken three times daily at the start (with the first bite) of each main meal. Acarbose Tablets should be started at a low dose, with gradual dose escalation as described below, both to reduce gastrointestinal side effects and to permit identification of the minimum dose required for adequate glycemic control of the patient. If the prescribed diet is not observed, the intestinal side effects may be intensified. If strongly distressing symptoms develop in spite of adherence to the diabetic diet prescribed, the doctor must be consulted and the dose temporarily or permanently reduced. During treatment initiation and dose titration (see below), one-hour postprandial plasma glucose may be used to determine the therapeutic response to Acarbose Tablets and identify the minimum effective dose for the patient. Thereafter, glycosylated hemoglobin should be measured at intervals of approximately three months. The therapeutic goal should be to decrease both postprandial plasma glucose and glycosylated hemoglobin levels to normal or near normal by using the lowest effective dose of Acarbose Tablets, either as monotherapy or in combination with sulfonylureas, insulin or metformin. Initial Dosage: The recommended starting dosage of Acarbose Tablets is 25 mg given orally three times daily at the start (with the first bite) of each main meal. However, some patients may benefit from more gradual dose titration to minimize gastrointestinal side effects. This may be achieved by initiating treatment at 25 mg once per day and subsequently increasing the frequency of administration to achieve 25 mg t.i.d. Maintenance Dosage: Once a 25 mg t.i.d. dosage regimen is reached, dosage of Acarbose Tablets should be adjusted at 4 to 8 week intervals based on one-hour postprandial glucose or glycosylated hemoglobin levels, and on tolerance. The dosage can be increased from 25 mg t.i.d. to 50 mg t.i.d. Some patients may benefit from further increasing the dosage to 100 mg t.i.d. The maintenance dose ranges from 50 mg t.i.d. to 100 mg t.i.d.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Acarbose side effects
▾
Stomach and digestive symptoms are by far the most common side effects of acarbose, and they're directly tied to how the medicine works:
Common side effects
- Gas (flatulence) — very common
- Diarrhea
- Stomach pain or discomfort
- Small drop in hematocrit (red blood cell volume)
- Low serum calcium levels
- Low vitamin B6 levels
- Abdominal pain or cramping
When to get medical help
- Call your doctor if you develop severe or persistent stomach pain, rectal bleeding, or mucus in your stool — these could be signs of a rare but serious bowel condition
- Get medical help right away if you notice yellowing of the skin or eyes, dark urine, or severe fatigue — these may signal liver problems
- If you experience signs of low blood sugar (shakiness, sweating, confusion) while also taking a sulfonylurea or insulin, contact your doctor — dose adjustments may be needed
- Seek emergency care for any rash, swelling, or severe allergic skin reaction
These digestive symptoms often improve over time with continued use and strict adherence to your prescribed diet. However, contact your doctor promptly if you notice yellowing of the skin or eyes, severe or persistent belly pain, rectal bleeding, rash, or any signs of a serious allergic reaction — these need medical attention right away.
Acarbose warnings and precautions
▾
- Liver injury: Elevated liver enzymes have been seen with acarbose, and rare but serious cases of hepatitis — including deaths — have been reported after the drug came to market. Your doctor may check your liver function periodically, especially at higher doses or if you weigh 60 kg (about 132 lbs) or less.
- Pneumatosis cystoides intestinalis: A rare condition where gas-filled cysts form in the intestinal wall has been reported. Symptoms include persistent diarrhea, mucus discharge, rectal bleeding, or constipation. If these occur, stop acarbose and seek evaluation immediately.
- Low blood sugar when combined with other diabetes medicines: Acarbose alone does not cause low blood sugar, but combining it with a sulfonylurea or insulin raises that risk. If low blood sugar occurs, it must be treated with glucose (dextrose), NOT sucrose (table sugar), because acarbose blocks sucrose breakdown.
- Not for everyone: Acarbose must not be used if you have diabetic ketoacidosis, cirrhosis, inflammatory bowel disease, bowel obstruction, or chronic digestive absorption disorders.
Acarbose interactions
▾
Several medicines and supplement types can interact with acarbose — either reducing its effect or increasing your risk of side effects:
- Sulfonylureas and insulin: Increase the risk of low blood sugar when combined with acarbose; dose adjustments may be needed.
- Digoxin: Acarbose can lower digoxin blood levels, potentially requiring a digoxin dose adjustment — your doctor should monitor this.
- Digestive enzyme supplements (amylase, pancreatin) and activated charcoal: Can reduce acarbose's effectiveness and should not be taken at the same time.
- Blood-sugar-raising medicines — including thiazide diuretics, corticosteroids, estrogens, oral contraceptives, phenytoin, thyroid products, nicotinic acid, sympathomimetics, and calcium channel blockers — may weaken acarbose's blood sugar control; close monitoring is needed.
- Metformin: Acarbose may slightly delay metformin absorption but does not have a clinically meaningful interaction overall.
Interactions listed in the FDA-approved label
From the Acarbose prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid: These drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. When given with acarbose, closely observe the patient for loss of blood glucose control; when withdrawn from patients receiving acarbose with sulfonylureas or insulin, observe closely for any evidence of hypoglycemia.
- Sulfonylureas or insulin: Acarbose in combination may cause a further lowering of blood glucose and may increase the potential for hypoglycemia; very rarely, individual cases of hypoglycemic shock have been reported. If hypoglycemia occurs, make appropriate adjustments in the dosage of these agents.
- Intestinal adsorbents (for example, charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (for example, amylase, pancreatin): May reduce the effect of acarbose tablets. Should not be taken concomitantly.
- Digoxin: Acarbose has been shown to change the bioavailability of digoxin when co-administered. May require digoxin dose adjustment.
Read the label’s full interactions text
Drug Interactions Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control. These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid. When such drugs are administered to a patient receiving acarbose tablets, the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from patients receiving acarbose tablets in combination with sulfonylureas or insulin, patients should be observed closely for any evidence of hypoglycemia. Patients Receiving Sulfonylureas or Insulin: Sulfonylurea agents or insulin may cause hypoglycemia. Acarbose tablets given in combination with a sulfonylurea or insulin may cause a further lowering of blood glucose and may increase the potential for hypoglycemia. If hypoglycemia occurs, appropriate adjustments in the dosage of these agents should be made. Very rarely, individual cases of hypoglycemic shock have been reported in patients receiving acarbose tablets therapy in combination with sulfonylureas and/or insulin. Intestinal adsorbents (for example, charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (for example, amylase, pancreatin) may reduce the effect of acarbose tablets and should not be taken concomitantly. Acarbose tablets has been shown to change the bioavailability of digoxin when they are co administered, which may require digoxin dose adjustment. (See CLINICAL PHARMACOLOGY , Drug-Drug Interactions ).
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Acarbose
▾
- Do not take acarbose if you have diabetic ketoacidosis, cirrhosis, inflammatory bowel disease, colonic ulceration, or a bowel obstruction.
- Do not take acarbose if you have chronic intestinal diseases that seriously affect digestion or absorption, or conditions that could worsen with increased intestinal gas.
- Tell your doctor if you have kidney disease — people with severe kidney impairment have much higher blood levels of acarbose, which may not be safe.
- If you weigh 60 kg (about 132 lbs) or less, higher doses carry increased risk of elevated liver enzymes; your doctor may limit your dose and monitor your liver.
- Tell your doctor about all medicines you take, especially other diabetes drugs, digoxin, digestive enzyme supplements, or activated charcoal products.
- Older adults may have somewhat higher acarbose levels in the blood, though this difference has not been found to be statistically significant in studies.
Acarbose overdose
▾
An overdose of acarbose — unlike overdoses of insulin or sulfonylureas — will not cause dangerous low blood sugar on its own. The most likely effects are temporary worsening of gas, diarrhea, and stomach discomfort.
If an overdose occurs, the label advises avoiding any drinks or foods containing carbohydrates (starches, sugars) for the next 4 to 6 hours, to prevent intensifying digestive symptoms.
What Acarbose does in the body
▾
Acarbose's main measurable effect is blunting the rise in blood sugar that normally follows a meal — known as postprandial hyperglycemia (high blood sugar after eating). By doing this consistently over time, it also lowers hemoglobin A1c (a marker of average blood sugar over roughly 3 months). It does not stimulate insulin secretion, and it does not cause weight gain — in fact, it may reduce the weight-gaining effect of sulfonylureas.
How your body processes Acarbose
▾
Acarbose is designed to act locally in the gut, and very little of the active drug — less than 2% of an oral dose — is absorbed into the bloodstream. It is broken down almost entirely within the gastrointestinal tract by intestinal bacteria and digestive enzymes. The small amount of active drug that does reach the blood is cleared quickly, with a half-life of about 2 hours, so it does not build up in the body with regular three-times-daily dosing.
People with severe kidney disease clear acarbose much more slowly, leading to significantly higher blood levels; this is an important consideration when prescribing. Older adults may also have modestly higher exposure, though this is not considered clinically significant based on available data.
How to store Acarbose
▾
Store at 20 o to 25 o C (68 o to 77 o F) . Protect from moisture.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Acarbose
281 supplements and herbal products have documented interactions with Acarbose in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 4
- Moderate · 240
- Minor · 37
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Acarbose has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Acarbose: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Acarbose — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does acarbose do, and why do I need to take it with meals?
▾
Will I get low blood sugar (hypoglycemia) from acarbose?
▾
Why am I so gassy and bloated since starting this medicine — is that normal?
▾
Are there any serious warning signs I should call my doctor about?
▾
Can I take my usual supplements or over-the-counter products while on acarbose?
▾
How will my doctor know if acarbose is actually working?
▾
Is Acarbose available over the counter?
▾
When was Acarbose first available?
▾
Who makes Acarbose?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Acarbose on HelloPharmacist
Acarbose forms and strengths (how it comes)
Acarbose is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Acarbose inactive ingredients by manufacturer.
Tablet
How this form is used
- Acarbose tablets are used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes
- Acarbose tablets may be used alone or combined with sulfonylureas, insulin, or metformin for additional blood sugar lowering
- Acarbose tablets should be taken three times daily at the very start (first bite) of each main meal
- Acarbose tablets should be started at a low dose and increased gradually to minimize stomach side effects — follow your prescriber's schedule
- If you are also taking a sulfonylurea or insulin, watch for signs of low blood sugar and contact your doctor if they occur
- Follow your prescribed diabetic diet closely — not doing so can worsen stomach-related side effects
Acarbose on the U.S. market: products, makers and brands
How Acarbose appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
6 companies list 17 Acarbose product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1995. Brand names on the directory include Prandase, Precose; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (5) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Acarbose is used (Medicaid data)
A general measure of how commonly Acarbose is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Acarbose is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Acarbose prescribed? Of the 1,601 medications we measure, Acarbose ranks #681 by Medicaid prescriptions — more than 57% of them.
Utilization by Acarbose product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
acarbose 50 MG Oral Tablet Most dispensed
Summed across the 3 of 38 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 199149
acarbose 25 MG Oral Tablet
Summed across the 3 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 200132
acarbose 100 MG Oral Tablet
Summed across the 3 of 28 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 199150
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Acarbose, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 9 of 92 listed Acarbose NDCs with Medicaid activity.
Compare Acarbose products
A representative set of FDA-listed product records for Acarbose — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 50 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 50 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 100 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 25 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 50 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 25 mg | Oral | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 50 mg | Oral | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 100 mg | Oral | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 25 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 50 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 100 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 25 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 50 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 100 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
Showing 17 of 17 products — FDA National Drug Code Directory. See every product, package size and price: browse all 17 Acarbose NDCs →
Acarbose side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Acarbose — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Acarbose in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Acarbose FDA approval history
How Acarbose went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Acarbose recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Acarbose recalls since July 2021.
✅No Acarbose recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 16681 1 dose form · 3 strengths
-
Dose form (SCDF) Oral Tablet RxCUI 370504In current FDA listings
Look up RxCUI 16681 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Acarbose supply and shortage status
Whether Acarbose is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Acarbose costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 50 mg | $0.169 per tablet | NDC details & price history |
| Tablet · Oral | 25 mg | $0.180 per tablet | NDC details & price history |
| Tablet · Oral | 100 mg | $0.274 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Acarbose brand names
Acarbose is sold under 2 brand names in the FDA directory — Prandase, Precose. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Acarbose: manufacturers and labelers
6 companies list Acarbose products with the FDA. By number of product records, the largest are Chartwell RX, LLC, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Hikma Pharmaceuticals USA Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Acarbose drug class (RxNorm)
Acarbose belongs to the alpha-Glucosidase Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Acarbose page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Bryant Ranch Prepack is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →